The 2012 Annual Report will be out within couple of weeks, and I expect that it will contain several nuggets of note.
-We'll be able to glean some sense of royalty income from POH's Body Shaper.
-Hopefully either in or released around the same time, an update on the NovoSkin BTM trial which should by now be well under way.
-Information on Director's holdings, whether they have added or shed shares in the last 12 months. I'll take encouragement if they have added shares.
Add to My Watchlist
What is My Watchlist?